Current Science

Open Access Open Access  Restricted Access Subscription Access

Mortality Trends of Breast Cancer in BRICS Countries from 1990 to 2019: An Age–Period–Cohort Analysis of the Global Burden of Disease Study 2019


Affiliations
1 Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
2 Department of Breast, The First People’s Hospital of Shao Guan, Shaoguan, Guangdong, China
 

Brazil, Russia, India, China and South Africa (BRICS) account for nearly half of the world’s population. We aimed to analyse mortality trends of breast cancer across the BRICS countries from 1990 to 2019. Breast cancer mortality estimates were obtained from the Global Burden of Disease Study 2019. An age–period–cohort model was adopted to estimate age, period and cohort effects on breast cancer mortality between 1990 and 2019. Results showed that breast cancer caused 0.23 million deaths across the BRICS countries in 2019, accounting for 32.7% of the total death caused by breast cancer worldwide. China had the largest number of deaths, followed by India. All five BRICS countries showed positive percentage changes in deaths from 1990 to 2019. The age-standardized mortality rates (ASMRs) in India, South Africa and China presented increased trends. South Africa presented the fastest increased rate with age. Downward period trends were observed in China, South Africa, Brazil and Russia, while an upward trend was seen in India, with the period rate ratio increasing from 0.95 to 1.17. In conclusion, the disease burden of breast cancer is still heavy across the BRICS countries. It is important to pay more attention to elderly patients. The increasing disease burden must be addressed multidimensionally, incorporating screening and early detection, timely and sufficient treatment and appropriate prevention.

Keywords

Age–Period–Cohort Model, Breast Cancer, BRICS, Disease Burden, Mortality.
User
Notifications
Font Size

  • Sung, H. et al., Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71, 209–249.

  • Fitzmaurice, C. et al., Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol., 2019, 5, 1749–1768.

  • Lin, L., Li, Z., Yan, L., Liu, Y., Yang, H. and Li, H., Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019. J. Hematol. Oncol., 2021, 14, 197.

  • Milosevic, M., Jankovic, D., Milenkovic, A. and Stojanov, D., Early diagnosis and detection of breast cancer. Technol. Health Care, 2018, 26, 729–759.

  • GBD 2017 Causes of Death Collaborators, Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet, 2018, 392, 1736–1788.

  • Acharya, S. et al., Brics and global health. Bull. World Health Organ., 2014, 92, 386–386a.

  • Marten, R. et al., An assessment of progress towards universal health coverage in Brazil, Russia, India, China and South Africa (BRICS). Lancet, 2014, 384, 2164–2171.

  • Jakovljevic, M. B. and Milovanovic, O., Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS. Front. Publ. Health, 2015, 3, 65.

  • Sun, P., Wen, H., Liu, X., Ma, Y., Jang, J. and Yu, C., Time trends in type-2 diabetes mellitus incidence across the BRICS from 1990 to 2019: an age-period-cohort analysis. BMC Publ. Health, 2022, 22, 65.

  • Zou, Z. et al., Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017. Circulation, 2020, 141, 790–799.

  • Bai, J., Zhao, Y., Yang, D., Ma, Y. and Yu, C., Secular trends in chronic respiratory diseases mortality in Brazil, Russia, China and South Africa: a comparative study across main brics countries from 1990 to 2019. BMC Publ. Health, 2022, 22, 91.

  • Liu, Q., Jing, W., Liu, M. and Liu, J., Health disparity and mortality trends of infectious diseases in BRICS from 1990 to 2019. J. Glob. Health, 2022, 12, 04028.

  • Liu, N. et al., Burden, trends, and risk factors for breast cancer in china from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea. BMC Cancer, 2022, 22, 826.

  • Basu, P., Zhang, L., Hariprasad, R., Carvalho, A. L. and Barchuk, A., A pragmatic approach to tackle the rising burden of breast cancer through prevention and early detection in countries ‘in transition’. Indian J. Med. Res., 2020, 152, 343–355.

  • Zhu, J. et al., Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence. Breast Cancer Res. Treat., 2020, 180, 449–459.

  • Rosenberg, P. S., Check, D. P. and Anderson, W. F., A web tool for age–period–cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol., Biomarkers Prevent., 2014, 23, 2296–2302.

  • Murray, C. J. L. et al., Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet, 2020, 396, 1223–1249.

  • Vos, T. et al., Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet, 2020, 396, 1204–1222.

  • GBD 2019 Demographics Collaborators, Global age-sex-specific fertility, mortality, healthy life expectancy (hale), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet, 2020, 396, 1160–1203.

  • Liu, Z. et al., The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J. Hepatol., 2019, 70, 674–683.

  • Ji, P., Gong, Y., Jin, M. L., Hu, X., Di, G. H. and Shao, Z. M., The burden and trends of breast cancer from 1990 to 2017 at the global, regional, and national levels: results from the global burden of disease study 2017. Front. Oncol., 2020, 10, 650.

  • Soerjomataram, I. et al., Cancer survival in Africa, Central and South America and Asia (Survcan-3): a population-based benchmarking study in 32 countries. Lancet Oncol., 2023, 24, 22–32.

  • Goss, P. E. et al., Challenges to effective cancer control in China, India, and Russia. Lancet Oncol., 2014, 15, 489–538.

  • Løberg, M., Lousdal, M. L., Bretthauer, M. and Kalager, M., Benefits and harms of mammography screening. Breast Cancer Res., 2015, 17, 63.

  • Solikhah, S., Promthet, S. and Hurst, C., Awareness level about breast cancer risk factors, barriers, attitude and breast cancer screening among Indonesian women. Asian Pac. J. Cancer Prevent., 2019, 20, 877–884.

  • Deandrea, S. et al., Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey. Prevent. Med., 2016, 91, 250–263.

  • Chen, X., Liu, X., Zhang, L., Li, S., Shi, Y. and Tong, Z., Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences. Jpn. J. Clin. Oncol., 2013, 43, 954–963.

  • Malvia, S., Bagadi, S. A., Dubey, U. S. and Saxena, S., Epidemiology of breast cancer in Indian women. Asia-Pac. J. Clin. Oncol., 2017, 13, 289–295.

  • Kumar, A., Bhagabaty, S. M., Tripathy, J. P., Selvaraj, K., Purkayastha, J. and Singh, R., Delays in diagnosis and treatment of breast cancer and the pathways of care: a mixed methods study from a tertiary cancer centre in north east india. Asian Pac. J. Cancer Preven., 2019, 20, 3711–3721.

  • Caleffi, M. et al., Breast cancer survival in brazil: how much health care access impact on cancer outcomes? Breast, 2020, 54, 155–159.

  • Schmidt, M. I. et al., Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet, 2011, 377, 1949–1961.

  • Anderson, B. O. et al., Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the breast health global initiative consensus, 2010. Lancet Oncol., 2011, 12, 387–398.

  • Barchuk, A. et al., Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol., 2018, 55, 73–80.

  • Hirte, L., Nolte, E., Bain, C. and McKee, M., Breast cancer mortality in Russia and Ukraine 1963–2002: an age–period–cohort analysis. Int. J. Epidemiol., 2007, 36, 900–906.

  • Rao, K. D., Petrosyan, V., Araujo, E. C. and McIntyre, D., Progress towards universal health coverage in BRICS: translating economic growth into better health. Bull. World Health Organ., 2014, 92, 429–435.

  • Singh, E., Joffe, M., Cubasch, H., Ruff, P., Norris, S. A. and Pisa, P. T., Breast cancer trends differ by ethnicity: a report from the South African National Cancer Registry (1994–2009). Eur. J. Publ. Health, 2017, 27, 173–178.

  • O’Neil, D. S. et al., Breast cancer care quality in South Africa’s public health system: an evaluation using American society of clinical oncology/national quality forum measures. J. Glob. Oncol., 2019, 5, 1–16.

  • Piffaretti, C., Moreno-Betancur, M., Lamarche-Vadel, A. and Rey, G., Quantifying cause-related mortality by weighting multiple causes of death. Bull. World Health Organ., 2016, 94, 870–879.


Abstract Views: 355

PDF Views: 120




  • Mortality Trends of Breast Cancer in BRICS Countries from 1990 to 2019: An Age–Period–Cohort Analysis of the Global Burden of Disease Study 2019

Abstract Views: 355  |  PDF Views: 120

Authors

Chaojian Chen
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Qiuping Yang
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Huiting Tian
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Jinyao Wu
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Lingzhi Chen
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Zeqi Ji
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Daitian Zheng
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Yexi Chen
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Zhiyang Li
Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Hai Lu
Department of Breast, The First People’s Hospital of Shao Guan, Shaoguan, Guangdong, China

Abstract


Brazil, Russia, India, China and South Africa (BRICS) account for nearly half of the world’s population. We aimed to analyse mortality trends of breast cancer across the BRICS countries from 1990 to 2019. Breast cancer mortality estimates were obtained from the Global Burden of Disease Study 2019. An age–period–cohort model was adopted to estimate age, period and cohort effects on breast cancer mortality between 1990 and 2019. Results showed that breast cancer caused 0.23 million deaths across the BRICS countries in 2019, accounting for 32.7% of the total death caused by breast cancer worldwide. China had the largest number of deaths, followed by India. All five BRICS countries showed positive percentage changes in deaths from 1990 to 2019. The age-standardized mortality rates (ASMRs) in India, South Africa and China presented increased trends. South Africa presented the fastest increased rate with age. Downward period trends were observed in China, South Africa, Brazil and Russia, while an upward trend was seen in India, with the period rate ratio increasing from 0.95 to 1.17. In conclusion, the disease burden of breast cancer is still heavy across the BRICS countries. It is important to pay more attention to elderly patients. The increasing disease burden must be addressed multidimensionally, incorporating screening and early detection, timely and sufficient treatment and appropriate prevention.

Keywords


Age–Period–Cohort Model, Breast Cancer, BRICS, Disease Burden, Mortality.

References





DOI: https://doi.org/10.18520/cs%2Fv125%2Fi2%2F148-155